Skip to main content
editorial
. 2021 Nov 27;15(3):388–392. doi: 10.1093/ckj/sfab240

Figure 2:

Figure 2:

Need to monitor the prescription of potentially nephrotoxic drugs to persons with CKD. The impact of monitoring clinical practice regarding the prescription of clearly nephrotoxic or potentially nephrotoxic drugs to persons with CKD requires awareness of the CKD diagnosis and may impact both individual patient care as well as the global care for persons with CKD.